Natera Q4 2023 Earnings Report
Key Takeaways
Natera reported a strong fourth quarter in 2023, with total revenues increasing by 43.2% compared to the same period in 2022, driven by a significant increase in product revenues and test volumes. The company also saw improvements in gross margin and a reduction in net loss per share.
Total revenues increased by 43.2% to $311.1 million compared to Q4 2022.
Product revenues increased by 44.3% to $307.3 million compared to Q4 2022.
Approximately 626,800 tests were processed in Q4 2023, compared to approximately 559,700 tests in Q4 2022.
Net loss for the fourth quarter of 2023 was $78.0 million, or ($0.65) per diluted share, compared to a net loss of $142.6 million, or ($1.37) per diluted share, for the same period in 2022.
Natera
Natera
Forward Guidance
Natera anticipates 2024 total revenue of $1.32 billion to $1.35 billion; 2024 gross margin to be approximately 50% to 53% of revenues; selling, general and administrative costs to be approximately $630 million to $650 million; research and development costs to be $325 million to $345 million, and net cash consumption to be $50 million to $75 million.